Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05079620 · ClinicalTrials.gov registry record · Phase 4
Early Antibiotics After Aspiration in ICU Patients
A Phase 4 study, sponsored by UConn Health.
- Terminated
- Registry status
- Phase 4
- Development phase
- 5
- Enrollment target
NCT05079620: Clinical Trial Phase 4 study, sponsored by UConn Health.
NCT05079620 is a Phase 4 study that was terminated before completion, run by UConn Health. The registered enrollment target is 5 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05079620, a Phase 4 study, was terminated before completion, sponsored by UConn Health.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 5 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the use of early antibiotics in ICU patients who appear to have aspirated, to help determine whether this improves outcomes by reducing the later incidence of pneumonia and other negative consequences.
Primary Outcome
Number of days not spent in the ICU, between date of admission and 30 days afterwards. Death or discharge can both reduce this measure.
Interventions
- DRUG Vancomycin
- DRUG Ceftriaxone
- DRUG Cefepime
- DRUG Levofloxacin
- DRUG Amoxicillin clavulanic acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2021-11-30 |
| Est. Completion | 2024-04-12 |
| Phase | Phase 4 |
Why NCT05079620 stopped before completion
NCT05079620 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 5 interventions - of which Vancomycin is the first listed.
NCT05079620 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05079620 about?
NCT05079620 is a clinical study titled "Early Antibiotics After Aspiration in ICU Patients". The purpose of this study is to evaluate the use of early antibiotics in ICU patients who appear to have aspirated, to help determine whether this improves outcomes by reducing the later incidence of pneumonia and other negative consequences.
What is the current status of trial NCT05079620?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 5 participants. The study started on 2021-11-30. Estimated completion is 2024-04-12.
What interventions are being tested in trial NCT05079620?
The interventions under investigation include: Vancomycin (DRUG), Ceftriaxone (DRUG), Cefepime (DRUG), Levofloxacin (DRUG), Amoxicillin clavulanic acid (DRUG).
Who is sponsoring clinical trial NCT05079620?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05079620's enrollment target sits among peer trials
5 1989th of 2000 higher than 7 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI